Canada markets close in 2 hours 20 minutes

Can-Fite BioPharma Ltd. (CANF)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.9500-0.0200 (-1.02%)
As of 01:39PM EDT. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-11,272
-7,634
-10,173
-12,615
-14,443
Depreciation & amortization
15
15
14
14
12
Stock based compensation
261
261
263
466
355
Change in working capital
-943
-943
-1,301
2,430
1,992
Accounts receivable
-
-
-
-
2,726
Accounts Payable
-469
-469
-58
393
-1,595
Other working capital
-8,442
-8,442
-10,810
-9,869
-12,089
Other non-cash items
-222
-222
113
-46
23
Net cash provided by operating activites
-8,440
-8,440
-10,801
-9,858
-12,063
Cash flows from investing activities
Investments in property, plant and equipment
-2
-2
-9
-11
-26
Purchases of investments
-
-
-
-14,500
0
Net cash used for investing activites
498
498
9,502
-14,511
-26
Cash flows from financing activities
Common stock issued
9,144
9,144
0
20,457
17,683
Net cash used privided by (used for) financing activities
9,144
9,144
0
20,457
17,683
Net change in cash
1,300
1,300
-1,412
-3,878
5,571
Cash at beginning of period
2,978
2,978
4,390
8,268
2,697
Cash at end of period
4,278
4,278
2,978
4,390
8,268
Free Cash Flow
Operating Cash Flow
-8,440
-8,440
-10,801
-9,858
-12,063
Capital Expenditure
-2
-2
-9
-11
-26
Free Cash Flow
-8,442
-8,442
-10,810
-9,869
-12,089